IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma

Bone destruction in multiple myeloma is characterized both by markedly increased osteoclastic bone destruction and severely impaired osteoblast activity. We reported that interleukin-3 (IL-3) levels are increased in bone marrow plasma of myeloma patients compared with healthy controls and that IL-3...

Ausführliche Beschreibung